Location History:
- Schlieren, CH (2016)
- Hombrechtikon, CH (2015 - 2017)
- Ottenbach, CH (2017 - 2022)
Company Filing History:
Years Active: 2015-2022
Title: Innovations of Julian Bertschinger
Introduction
Julian Bertschinger is a notable inventor based in Ottenbach, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that bind to fibroblast growth factor receptor 3 isoforms. With a total of eight patents to his name, Bertschinger's work is recognized for its potential applications in medical science.
Latest Patents
One of his latest patents involves FGFR3 binding molecules. This invention relates to a polypeptide that binds to fibroblast growth factor receptor 3 isoforms 3b and 3c (FGFR3b and FGFR3c). The polypeptide comprises an amino acid sequence selected from several groups, including sequences that maintain specific conserved amino acids. The detailed sequences include variations that allow for a high degree of identity while preserving critical functional components.
Career Highlights
Throughout his career, Julian Bertschinger has worked with prominent companies in the biotechnology sector. Notable among these are Covagen AG and Cilag International GmbH. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field.
Collaborations
Bertschinger has collaborated with several professionals in his field, including Dragan Grabulovski and Patricia Henne. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.
Conclusion
Julian Bertschinger's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.